NCT06497413Completed
Brain Vascular and Neurocognitive Health
Source: ClinicalTrials.gov · Last updated 6 Oct 2025
Brief summary (registry, in English)
The overall research objective of this proposal is to determine the acute and chronic impact of transcranial photobiomodulation on indices of cerebral vascular health and neurocognitive function.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 24 (actual)
- First submitted
- 10 Jun 2024
- Start date
- 16 Apr 2024
- Primary completion date
- 31 Aug 2025
- Lead sponsor
- The University of Texas at Arlington
- Diseases
- Alzheimer disease
- NCT number
- NCT06497413
What you commit to
- Study type: Interventional
- Participants enrolled: 24
- From 16 Apr 2024 to the primary completion date, 31 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- If a subject has any allergies to spandex/lycra, the subject will be excluded. However, latex allergies are not contraindicated.
- Individuals with cardiac pacemakers and/or implantable cardioverter defibrillators and individuals with epilepsy will be excluded.
Age
- Pregnant subjects, women who are breast feeding, and children (i.e. younger than 18) will not be recruited for the study. This will be assessed via self-report.
Other
- Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then the investigators may still opt to proceed with data collection.
- Abnormal results from the blood screening will not impact eligibility for the study.
- Individuals with brain injuries/surgeries in a year before the study and individuals who can not provide consent on their own will be excluded from participation.
Who the study is looking for
- Both men and women between the ages of 18-80 and of any race/ethnicity will be included in this study.
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Arlington - Science and Engineering Innovation and Research Building Coordinator of this site? Confirm its status | Arlington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.